Ledger.Open graph →
SEC Form D · filed May 16, 2018

Nohla Therapeutics Inc

Offering
$58.4M
Sold
$45.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Steven Gillis · Ann Arbor, MIDirectorJim Johnson · Oneida, TNExecLawrence Gozlan · Seattle, WADirectorMichael Sistenich · Seattle, WADirectorBrian Daniels · Research Triangle Park, NCDirectorGary Christianson · Seattle, WAExecColleen Delaney · Seattle, WAExecKathleen Fanning · Seattle, WAExec · DirectorSteven Gillis · Chicago, ILDirectorJim Johnson · Centennial, COExecLawrence Gozlan · Seattle, WADirectorMichael Sistenich · Seattle, WADirectorBrian Daniels · Research Triangle Park, NCDirectorGary Christianson · Seattle, WAExecColleen Delaney · Seattle, WAExecKathleen Fanning · Seattle, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗